Skip to main content Accessibility help
×
Home
Hostname: page-component-568f69f84b-tcbk7 Total loading time: 0.17 Render date: 2021-09-17T20:39:33.972Z Has data issue: true Feature Flags: { "shouldUseShareProductTool": true, "shouldUseHypothesis": true, "isUnsiloEnabled": true, "metricsAbstractViews": false, "figures": true, "newCiteModal": false, "newCitedByModal": true, "newEcommerce": true, "newUsageEvents": true }

Co-occurring mental disorder and substance use disorder in young people: aetiology, assessment and treatment

Published online by Cambridge University Press:  15 September 2020

John Otasowie*
Affiliation:
MBBS, FRCPC (Can), FRCPsych (UK), is a consultant child and adolescent psychiatrist with the Fraser Health Authority, working in the Child and Adolescent Psychiatric Stabilization Unit at Surrey Memorial Hospital, British Columbia, Canada. He provides psychiatric consultation to the regional youth concurrent disorder and eating disorders programmes.
*Corresponding
Correspondence John Otasowie. Email: john.otasowie@fraserhealth.ca

Summary

Dual diagnosis is one of several terms used to identify individuals diagnosed with a co-occurring mental disorder and substance use disorder. The existence of a dual diagnosis in adolescents is often associated with functional impairment in various life domains, causing physical health problems, relational conflicts, educational/vocational underachievement and legal problems. Dual diagnosis is difficult to treat and can result in tremendous economic burden on healthcare, education and justice systems. It is essential for clinicians caring for young people to be knowledgeable about dual diagnosis to ensure that it is identified early and treated. This article aims to provide an overview of dual diagnosis, increase its awareness and promote a realistic treatment approach.

Type
Article
Copyright
Copyright © The Author 2020

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

American Psychiatric Association (2013) Diagnostic and Statistical Manual of Mental Disorders (5th edn) (DSM-5). American Psychiatric Publishing.Google Scholar
Asarnow, JR, Rozenman, M, Wiblin, J, et al. (2015) Integrated medical-behavioral care compared with usual primary care for child and adolescent behavioral health: a meta-analysis. JAMA Pediatrics, 169: 929–37.CrossRefGoogle ScholarPubMed
Bender, K, Springer, DW, Kim, JS (2006) Treatment effectiveness with dually diagnosed adolescents: a systematic review. Brief Treatments and Crisis Intervention, 6: 177205.CrossRefGoogle Scholar
Blumenthal, D, Gokhale, M, Campbell, EG, et al. (2001) Preparedness for clinical practice: reports of graduating residents at academic health centers. JAMA, 286: 1027–34.CrossRefGoogle ScholarPubMed
Bukstein, OG, Horner, MS (2010) Management of the adolescent with substance use disorders and comorbid psychopathology. Child and Adolescent Psychiatric Clinics of North America, 19: 609–23.CrossRefGoogle ScholarPubMed
Casey, BJ, Jones, RM (2010) Neurobiology of the adolescent brain and behavior: implications for substance use disorders. Journal of the American Academy of Child & Adolescent Psychiatry, 49: 1189–201.Google ScholarPubMed
Catchpole, RE, Brownlie, EB (2016) Characteristics of youth presenting to a Canadian youth concurrent disorders program: clinical complexity, trauma, adaptive functioning and treatment priorities. Journal of the Canadian Academy of Child and Adolescent Psychiatry, 25: 106–15.Google ScholarPubMed
Chan, Y-F, Dennis, ML, Funk, RR (2008) Prevalence and comorbidity of major internalizing and externalizing problems among adolescents and adults presenting to substance abuse treatment. Journal of Substance Abuse Treatment, 34: 1424.CrossRefGoogle ScholarPubMed
Cornelius, JR, Clark, DB, Bukstein, OG, et al. (2005) Acute phase and five-year follow-up study of fluoxetine in adolescents with major depression and a comorbid substance use disorder: a review. Addictive Behaviors, 30: 1824–33.CrossRefGoogle Scholar
Cunill, R, Castells, X, Tobias, A, et al. (2015) Pharmacological treatment of attention deficit hyperactivity disorder with co-morbid drug dependence. Journal of Psychopharmacology, 29: 1523.CrossRefGoogle ScholarPubMed
Dennis, ML, Chan, YF, Funk, RR (2006) Development and validation of the GAIN Short Screener (GSS) for internalizing, externalizing and substance use disorders and crime/violence problems among adolescents and adults. American Journal on Addictions, 15: 8091.CrossRefGoogle ScholarPubMed
DeQuardo, JR, Carpenter, CF, Tandon, R (1994) Patterns of substance abuse in schizophrenia: nature and significance. Journal of Psychiatric Research, 28: 267–75.CrossRefGoogle ScholarPubMed
Duncan, BL, Miller, SD, Sparks, JA, et al. (2003) The Session Rating Scale: preliminary psychometric properties of a “working” alliance measure. Journal of Brief Therapy, 3: 312.Google Scholar
Erskine, HE, Moffitt, TE, Copeland, WE, et al. (2015) A heavy burden on young minds: the global burden of mental and substance use disorders in children and youth. Psychological Medicine, 45: 1551–63.CrossRefGoogle Scholar
Hawkins, JD, Catalano, RF, Miller, JY (1992) Risk and protective factors for alcohol and other drug problems in adolescence and early adulthood: implications for substance abuse prevention. Psychological Bulletin, 112: 64105.CrossRefGoogle ScholarPubMed
Jordan, CJ, Andersen, SL (2017) Sensitive periods of substance abuse: early risk for the transition to dependence. Developmental Cognitive Neuroscience, 25: 2944.CrossRefGoogle ScholarPubMed
Kalina, K, Vácha, P (2013) Dual diagnoses in therapeutic communities for addicts – possibilities and limits of integrated treatment. Adiktologie/Addictology, 13: 144–65.Google Scholar
Kampman, K, Jarvis, M (2015) American Society of Addiction Medicine (ASAM) national practice guideline for the use of medications in the treatment of addiction involving opioid use. Journal of Addiction Medicine, 9: 358–67.CrossRefGoogle ScholarPubMed
Kelly, TM, Daley, DC, Doualhy, AB (2012) Treatment of substance abusing patients with comorbid psychiatric disorders. Addictive Behaviors, 37: 1124.CrossRefGoogle ScholarPubMed
Khantzian, EJ (1997) The self-medication hypothesis of substance use disorders: a reconsideration and recent applications. Harvard Review of Psychiatry, 4: 231–44.CrossRefGoogle ScholarPubMed
Khokhar, JY, Dwiel, LL, Henricks, AM, et al. (2018) The link between schizophrenia and substance use disorder: a unifying hypothesis. Schizophrenia Research, 194: 7885.CrossRefGoogle ScholarPubMed
Knight, JR, Shrier, LA, Bravender, TD, et al. (1999) A new brief screen for adolescent substance abuse. Archives of Pediatric and Adolescent Medicine, 153: 591–6.CrossRefGoogle ScholarPubMed
Levy, S, Williams, JF, Committee on Substance Abuse (2016) Substance use screening, brief intervention, and referral to treatment. Pediatrics, 138(1): e20161211.CrossRefGoogle ScholarPubMed
Lichtenstein, DP, Spirito, A, Zimmermann, RP (2010) Assessing and treating co-occurring disorders in adolescents: examining typical practice of community-based mental health and substance abuse treatment providers. Community Mental Health Journal, 46: 252–7.CrossRefGoogle Scholar
Marshall, EJ (2014) Adolescent alcohol use: risks and consequences. Alcohol and Alcoholism, 49: 160–4.CrossRefGoogle ScholarPubMed
Merikangas, KR, He, J, Burstein, M, et al. (2010) Lifetime prevalence of mental disorders in U.S. adolescents: results from the National Comorbidity Survey Replication – Adolescent Supplement (NCS-A). Journal of the American Academy of Child & Adolescent Psychiatry, 49: 980–9.CrossRefGoogle Scholar
Miller, SD, Duncan, BL, Brown, J, et al. (2003) The Outcome Rating Scale: a preliminary study of the reliability, validity, and feasibility of a brief visual analog measure. Journal of Brief Therapy, 2: 91100.Google Scholar
Miller, SD, Duncan, BL, Sorrell, R, et al. (2005) The partners for change outcome management system. Journal of Clinical Psychology, 61: 199208.CrossRefGoogle ScholarPubMed
Miranda, R, Ray, L, Blanchard, A, et al. (2014) Effects of naltrexone on adolescent alcohol cue reactivity and sensitivity: an initial randomized trial. Addiction Biology, 19: 941–54.CrossRefGoogle Scholar
Mustonen, A, Niemelä, S, Nordström, T, et al. (2018) Adolescent cannabis use, baseline prodromal symptoms and the risk of psychosis. British Journal of Psychiatry, 212: 227–33.CrossRefGoogle ScholarPubMed
National Institute for Health and Care Excellence (2016) Coexisting Severe Mental Illness and Substance Misuse: Community Health and Social Care Services (NICE Guideline NG58). NICE.Google Scholar
Ramchand, R, Griffin, BA, Hunter, SB, et al. (2015) Provision of mental health services as a quality indicator for adolescent substance abuse treatment facilities. Psychiatric Services, 66: 41–8.CrossRefGoogle ScholarPubMed
Roten, AT, Baker, NL, Gray, KM (2013) Marijuana craving trajectories in an adolescent marijuana cessation pharmacotherapy trial. Addictive Behaviors, 38: 1788–91.CrossRefGoogle Scholar
Saitz, R (2010) Alcohol screening and brief intervention in primary care: absence of evidence for efficacy in people with dependence or very heavy drinking. Drug and Alcohol Review, 29: 631–40.CrossRefGoogle ScholarPubMed
Sterling, S, Weisner, C, Hinman, A, et al. (2010) Access to treatment for adolescents with substance use and co-occurring disorders: challenges and opportunities. Journal of the American Academy of Child & Adolescent Psychiatry, 49: 637–46.Google ScholarPubMed
Winstanley, EL, Steinwachs, DM, Stitzer, ML, et al. (2012) Adolescents substance abuse and mental health: problem co-occurrence and access to services. Journal of Child & Adolescent Substance Abuse, 21: 310–22.CrossRefGoogle ScholarPubMed
Winters, KC, Tanner-Smith, EE, Bresani, E, et al. (2014) Current advances in the treatment of adolescent drug use. Adolescent Health, Medicine and Therapeutics, 5: 199210.CrossRefGoogle ScholarPubMed
Wu, L-T, Gersing, K, Burchett, B, et al. (2011) Substance use disorders and comorbid Axis I and II psychiatric disorders among young psychiatric patients: findings from a large electronic health records database. Journal of Psychiatric Research, 45: 1453–62.CrossRefGoogle ScholarPubMed
Youngblade, LM, Theokas, C, Schulenberg, J, et al. (2007) Risk and promotive factors in families, school, and communities: a contextual model of positive youth development in adolescence. Pediatrics, 119(suppl 1): s47S53.CrossRefGoogle ScholarPubMed
Zhou, X, Qin, B, Del Giovane, C, et al. (2015) Efficacy and tolerability of antidepressants in the treatment of adolescents and young adults with depression and substance use disorders: a systematic review and meta-analysis. Addiction, 110: 3848.CrossRefGoogle Scholar
Supplementary material: PDF

Otasowie supplementary material

Otasowie supplementary material

Download Otasowie supplementary material(PDF)
PDF 1 MB
Submit a response

eLetters

No eLetters have been published for this article.

Send article to Kindle

To send this article to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.

Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Co-occurring mental disorder and substance use disorder in young people: aetiology, assessment and treatment
Available formats
×

Send article to Dropbox

To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.

Co-occurring mental disorder and substance use disorder in young people: aetiology, assessment and treatment
Available formats
×

Send article to Google Drive

To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.

Co-occurring mental disorder and substance use disorder in young people: aetiology, assessment and treatment
Available formats
×
×

Reply to: Submit a response

Please enter your response.

Your details

Please enter a valid email address.

Conflicting interests

Do you have any conflicting interests? *